Trial Profile
Efficacy and safety of filgrastim biosimilar versus filgrastim for Autologous Stem Cell Transplantation : A retrospective analysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2016
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Lymphoma
- Focus Therapeutic Use
- 28 Sep 2016 New trial record